Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague Dawley Rats

Endoxifen (4-hydroxyl-N-desmethyl tamoxifen), one of the major active metabolites of tamoxifen, has substantially greater estrogen antagonist properties and antiproliferative effects in breast tumor cells than tamoxifen, a mixed estrogen agonist/antagonist. An associated risk of endometrial cancer a...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Schweikart, Karen M., Eldridge, Sandy R., Safgren, Stephanie L., Parman, Toufan, Reid, Joel M., Ames, Matthew M., Goetz, Matthew P., Davis, Myrtle A.
Hōputu: Text
Reo:Ingarihi
I whakaputaina: 2014
Ngā marau:
Urunga tuihono:https://pmc.ncbi.nlm.nih.gov/articles/PMC4177029/
https://pubmed.ncbi.nlm.nih.gov/24670817
http://dx.doi.org/10.1177/0192623314525688
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!